Rchr
J-GLOBAL ID:200901038338149757
Update date: Mar. 01, 2024
HASEGAWA Kosei
HASEGAWA Kosei
Affiliation and department:
Job title:
Professor
Homepage URL (1):
http://www.saitama-med.ac.jp/kokusai/fujinshuyo/
Research theme for competitive and other funds (6):
Papers (79):
-
Takeda A, Kobayashi M, Hasegawa K, Fujimaki T. Cancer Susceptibility Gene 1 (BRCA1) Germline Mutation. Cureus. Cureus. 2023
-
Yonemori K, Yunokawa M, Ushijima K, Sakata J, Shikama A, Minobe S, Usami T, Enomoto T, Takehara K, Hasegawa K, et al. Lenvatinib plus pembrolizumab in Japanese patients with endometrial cancer: Results from Study 309/KEYNOTE-775. Cancer Science. 2022. 3489-3497
-
Nishio S, Yonemori K, Usami T, Minobe S, Yunokawa M, Iwata T, Okamoto A, Aoki Y, Itamochi H, Takekuma M, et al. Pembrolizumab plus chemotherapy in Japanese patients with persistent, recurrent or metastatic cervical cancer: Results from KEYNOTE-826. Cancer Science. 2022. 3877-3887
-
Yonemori K, Kuboki Y, Hasegawa K, Iwata T, Kato H, Takehara K, Hirashima Y, Kato H, Passey C, Buchbjerg JK, et al. Tisotumab vedotin in Japanese patients with recurrent/metastatic cervical cancer: Results from the innovaTV 206 study. Cancer Science. 2022. 2788-2797
-
Sato S, Matsushita H, Shintani D, Kobayashi Y, Fujieda N, Yabuno A, Nishikawa T, Fujiwara K, Kakimi K, Hasegawa K. Association between effector-type regulatory T cells and immune checkpoint expression on CD8+ T cells in malignant ascites from epithelial ovarian cancer. BMC Cancer. 2022
more...
Lectures and oral presentations (24):
-
HDAC6 as a therapeutic target for ovarian clear cell carcinoma, in association with ARID1A loss
(17th Biennial Meeting of the International Gynecologic Cancer Society 2018)
-
Soluble folate receptor alpha as a biomarker for epithelial ovarian cancer
(72th Japanese Cancer Association 2013)
-
Redirected antitumor activity of an engineered Sendai virus vector in ovarian cancer cells
(AACR/JCA 2013)
-
Tumor Board I: Clear cell carcinoma of the uterus
(14th Biennial Meeting of the International Gynecologic Cancer Society 2012)
-
Soluble MUC1 as a Biomarker for Epithelial Ovarian Cancer
(14th Biennial Meeting of the International Gynecologic Cancer Society 2012)
more...
Education (2):
- 2000 - 2004 Okayama University Graduate School, Division of Medicine
- 1991 - 1997 Okayama University Graduate School, Division of Medicine
Professional career (2):
- 医学士 (岡山大学)
- 医学博士 (岡山大学大学院)
Work history (8):
- 2006/10 - 2008/09 University of Pennsylvania Ovarian Cancer Research Center Researher Postdoc
- 2006/10 - 2008/09 University of Pennsylvania Ovarian Cancer Research Center Researcher
- 2006/10 - 2008/09 University of Pennsylvania Ovarian Cancer Research Center Researcher
- 2004/09 - 2006/09 Mayo Clinic Department of Molecular Medicine Researher Postdoc
- 2004/09 - 2006/09 Mayo Clinic Department of Molecular Medicine Researcher
- 2004/09 - 2006/09 Mayo Clinic Department of Molecular Medicine Researcher
- 2003/04 - 2004/08 岡山済生会総合病院 産婦人科 医師
- 2003/04 - 2004/08 医師
Show all
Return to Previous Page